Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current antibiotics for clinical practice]

W Zimmerli1

  • 1Departement für Innere Medizin, Universitätskliniken, Kantonsspital Basel.

Praxis
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathogenesis and management of fracture-related infection.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Debridement and implant retention in the management of hip periprosthetic joint infection: outcomes following guided and rapid treatment at a single centre.

The bone & joint journal·2017
Same author

[Orthopaedic implant-associated infections: Update of antimicrobial therapy].

Der Orthopade·2015
Same author

Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study.

Journal of internal medicine·2014
Same author

The treatment and outcome of peri-prosthetic infection of the ankle: a single cohort-centre experience of 34 cases.

The bone & joint journal·2014
Same author

Clinical presentation and treatment of orthopaedic implant-associated infection.

Journal of internal medicine·2014
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
Same journal

[Postoperative serotonin syndrome in a patient with attention-deficit/hyperactivity disorder and treatment-resistant depression].

Praxis·2026
See all related articles

New oral antibiotics like cephalosporins, fluoroquinolones, and macrolides offer improved efficacy for common infections. However, older agents remain crucial, and antimicrobial resistance is a growing concern.

Area of Science:

  • Pharmacology
  • Infectious Diseases

Context:

  • The development of novel oral antimicrobial agents has expanded treatment options for bacterial infections.
  • Practitioners now have access to advanced cephalosporins, fluoroquinolones, and macrolides.

Purpose:

  • To review the key characteristics and clinical applications of new oral antimicrobial agents.
  • To compare the efficacy, spectrum of activity, and indications of novel antibiotics against older treatments.

Summary:

  • New oral cephalosporins offer enhanced beta-lactamase stability and longer half-lives, primarily targeting gram-negative bacteria in ENT and UT infections.
  • Fluoroquinolones exhibit excellent bioavailability and gram-negative activity, indicated for UT, bone, and joint infections, though resistance is a concern.
  • New macrolides like clarithromycin and azithromycin provide improved pharmacokinetics and reduced side effects, effective against respiratory tract infections and other conditions.

Related Experiment Videos

Impact:

  • These advancements provide clinicians with more effective oral treatment strategies for various bacterial infections.
  • Understanding the comparative advantages and limitations of these agents is vital for optimizing patient outcomes and combating antimicrobial resistance.